Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Omega Protein Corp (OME): Wynnefield Capital Trims Some Fat From Its Stake

Page 1 of 14

According to an amended 13D filing with the Securities and Exchange Commission, Nelson Obus and Joshua Landes Wynnefield Capital decreased its stake in Omega Protein Corp (NYSE:OME) to 1.37 million shares, which represent 6.2% of the company’s outstanding shares. According to its 13F filing for the end of June, the stake previously consisted of 1.77 million common shares.

Omega Protein is a food business company that produces nutritious products and operates in two sectors: animal nutrition and human nutrition. Over the past 12 months, the company’s shares have gained 39.77%. For the second quarter of 2016, Omega Protein reported earnings per share of $0.62 and revenue of $112.7 million, compared to EPS of $0.43, and revenue of $93.2 million for the same period a year earlier. Earlier this month, DA Davidson boosted its price target on Omega Protein’s stock to $26 from $20, maintaining a ‘Neutral’ rating on it, while Wunderlich downgraded the stock to ‘Hold’ from ‘Buy’ but raised its price target on it to $26 from $22, and Pivotal Research boosted its price target to $30 from $25, and has a ‘Buy’ rating on the stock.

Nelson Obus

Investors in our database long Omega Protein Corp (NYSE:OME) at the end of June, aside from Wynnefield Capital, included Peter Algert and Kevin Coldiron’s Algert Coldiron Investors, with a position worth $874,000, Louis Navellier’s Navellier & Associates, which held a position valued at $284,000, and Gavin Saitowitz and Cisco J. Del Valle’s Springbok Capital. Some of the new investors in Omega Protein Corp (NYSE:OME) during the second quarter were Ken Griffin’s Citadel Investment Group, which had a $524,000 position in the company at the end of the period, and Robert B. Gillam’s McKinley Capital Management, which initiated a position worth $5,000 at the end of June.

Follow Omega Protein Corp (NYSE:OME)
Trade (NYSE:OME) Now!

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Wynnefield Partners Small Cap Value 442,982 0 442,982 0 442,982 2.0%
Wynnefield Partners Small Cap Value 730,327 0 730,327 0 730,327 3.3%
Wynnefield Small Cap Value Offshore Fund, Ltd. (No 113,754 0 113,754 0 113,754 0.5%
Wynnefield Capital, Inc. Profit Sharing Money Purchase Plan 85,000 0 85,000 0 85,000 0.4%
Wynnefield Capital Management 1,173,309 0 1,173,309 0 1,173,309 5.3%
Wynnefield Capital, Inc. 13-3688495 113,754 0 113,754 0 113,754 0.5%
Nelson Obus 0 1,372,063 0 1,372,063 1,372,063 6.2%
Joshua Landes 0 1,372,063 0 1,372,063 1,372,063 6.2%

Nelson Obus
Nelson Obus
Wynnefield Capital

Page 1 of 14 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D/A

(Amendment No. 7)

Under the Securities Exchange Act of 1934

OMEGA PROTEIN CORPORATION

(Name of Issuer)

 

Common Stock, $0.01 par value

(Title of Class of Securities)

 

68210P107

(CUSIP Number)

Wynnefield Partners Small Cap Value, L.P.

450 Seventh Avenue, Suite 509

New York, New York 10123

Attention: Mr. Nelson Obus

Copy to:

Jeffrey S. Tullman, Esq.

Kane Kessler, P.C.

1350 Avenue of the Americas, 26th Floor

New York, New York 10019

(212) 541-6222

(Name, Address and Telephone
Number of Person Authorized to Receive Notices and Communications)

August 11, 2016

(Date of Event which requires Filing of
this Statement)

If the filing person has previously filed
a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because
of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨

Follow Omega Protein Corp (NYSE:OME)
Trade (NYSE:OME) Now!
Page 1 of 14
Loading Comments...